AKT1 and metabolic dysfunction-associated steatotic liver disease: These DEGs are involved in various KEGG pathways, including metabolic pathways, ECM-receptor interaction, nonalcoholic fatty liver disease (NAFLD), focal adhesion, PI3K-Akt signaling pathway, regulation of lipolysis in adipocytes, AMPK signaling pathway, insulin resistance, and sphingolipid metabolism.